Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without

A Groth1, J D Weber, B M Willumsen

  • 1Department of Tumor Cell Biology and Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Insights

Oncogenic Ras triggers senescence via INK4a/ARF tumor suppressors. In cells lacking key cell cycle inhibitors, Ras promotes abnormal cell division and polyploidy, impacting cell cycle completion.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Tumor Suppressor Genes

Background:

  • Oncogenic Ras is a key driver of cellular transformation and senescence.
  • The INK4a/ARF locus encodes p16(INK4a) and p19(ARF), critical tumor suppressors.
  • p16(INK4a) inhibits cyclin D-dependent kinases, while p19(ARF) activates p53.

Purpose of the Study:

  • To investigate the role of oncogenic Ras in cell cycle regulation, particularly in the absence of specific cell cycle inhibitors.
  • To understand the interplay between Ras, INK4a/ARF, and cyclin-dependent kinase inhibitors (CKIs) in cell proliferation and transformation.

Main Methods:

  • Utilized primary human and rodent fibroblasts, including immortalized cell lines and genetically modified mouse embryo fibroblasts.
  • Examined the expression of p16(INK4a) and p19(ARF) in response to oncogenic Ras.
  • Analyzed cell cycle progression, DNA synthesis, nuclear division, cytokinesis, and ploidy in cells with varying genetic backgrounds.

Main Results:

  • Oncogenic Ras induces p16(INK4a) and p19(ARF) in normal fibroblasts, causing cell cycle arrest.
  • Cells lacking INK4a/ARF, ARF, or p53 are resistant to Ras-induced growth inhibition.
  • In fibroblasts lacking p21(Cip1) and p27(Kip1), Ras induced p19(ARF) but not p16(INK4a), leading to abnormal cell division and polyploidy instead of G1 arrest.

Conclusions:

  • p16(INK4a) and p19(ARF) are crucial mediators of Ras-induced senescence.
  • The absence of CKIs like p21(Cip1) and p27(Kip1) alters Ras's effect on the cell cycle, bypassing G1 arrest.
  • Oncogenic Ras can disrupt cell cycle completion through mechanisms independent of canonical senescence pathways when key inhibitors are absent.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...